Bourgeon Capital Management LLC Pds Biotechnology Corp Transaction History

Bourgeon Capital Management LLC

  • $521 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$2.28 - $6.81 $5,244 - $15,663
-2,300 Closed
0 $0
Q4 2020

Jan 29, 2021
BUY
$1.91 - $2.67 $1,528 - $2,136
800 Added 53.33%
2,300 $5,000
Q3 2020

Oct 28, 2020
BUY
$1.67 - $4.67 $2,505 - $7,005
1,500 New
1,500 $3,000

Others Institutions Holding PDSB

# of Institutions
61
Shares Held
4.26M
Call Options Held
163K
Put Options Held
6.1K
View Full List

About PDS Biotechnology Corp

PDSB Quotes by TradingView
  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $44.4M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Bourgeon Capital Management LLC Portfolio

Follow Bourgeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bourgeon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email